Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Speck Design Delivers Solutions for Two Complex Consumer Products for Social Good

February 23, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Feb. 23, 2011 /- Complications during development led two product development companies to turn to Speck Design in recent months for an inventive approach and mechanical design that would deliver top-quality products on deadline.  The first product, Zamzee, had an...

Reportlinker Adds Global Orthopedic Prosthetics Industry

February 23, 2011 2:37 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 23, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Orthopedic Prosthetics Industry http://www.reportlinker.com/p090647/Global-Orthopedic-Prosthetics-Industry.html This report analyzes the worldwide markets for...

Perceptive Informatics Integrates Medical Imaging Tracking with RTSM Technologies for Streamlined Workflow, Improved Data Quality

February 23, 2011 2:37 am | by Bio-Medicine.Org | News | Comments

BOSTON, Feb. 23, 2011 /- Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL ), today announced the next level of seamless integration between its Medical Imaging Tracking application and ClinPhone®...

Advertisement

NHS Hearing Aids - Free But at What Price?

February 23, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

PRESTON, England, Feb. 23, 2011 /- In the UK we are fortunate enough to have a free provision of hearing aids by way of the NHS. Over the last few years, the NHS has switched from analogue to digital hearing aids for the majority of patients. These hearing instruments are of a reasonable...

Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials

February 22, 2011 11:36 pm | by Bio-Medicine.Org | News | Comments

LONDON, Feb. 23, 2011 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office (USPTO).  The issued patent, which represents a...

High Rates of Pathological Complete Response in Patients with Advanced Esophageal Cancer in OPAXIOâ„¢ Phase II Study Reported in American Journal of Clinical Oncology

February 22, 2011 11:35 pm | by Bio-Medicine.Org | News | Comments

SEATTLE, Feb. 23, 2011 /- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that updated phase II study results of OPAXIO (paclitaxel poliglumex) in patients with advanced esophageal cancer conducted by the Brown University Oncology Group were published in the...

Johnson & Johnson to Participate in 2011 Citi Global Health Care Conference

February 22, 2011 11:35 am | by Bio-Medicine.Org | News | Comments

NEW BRUNSWICK, N.J., Feb. 22, 2011 /- Johnson & Johnson (NYSE: JNJ ) will participate in the 2011 Citi Global Health Care Conference on Tuesday, March 1, at the Hilton New York Hotel in New York, N.Y.  Joaquin Duato, Worldwide Chairman, Pharmaceuticals, will represent the Company...

Zell Lurie Institute Awards $106,300 to University of Michigan Students Through the Michigan Business Challenge and Dare to Dream Startup Grant Program

February 22, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., Feb. 22, 2011 /PRNewswire-USNewswire/ -- The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business today announced winners of its 2010-2011 Michigan Business Challenge competition awards and Eugene...

Advertisement

Reportlinker Adds Global Orthopedic Instrumentation Industry

February 22, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 22, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Orthopedic Instrumentation Industry http://www.reportlinker.com/p098382/Global-Orthopedic-Instrumentation-Industry.html This report analyzes the worldwide markets...

Reportlinker Adds North American Pneumatic Accessories Market

February 22, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 22, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: North American Pneumatic Accessories Market http://www.reportlinker.com/p0402399/North-American-Pneumatic-Accessories-Market.html This research covers the state of the...

Reportlinker Adds Global Intraocular Lenses Industry

February 22, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 22, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Intraocular Lenses Industry http://www.reportlinker.com/p098379/Global-Intraocular-Lenses-Industry.html This report analyzes the worldwide markets for Intraocular...

Reportlinker Adds Global Disposable Medical Gloves Industry

February 22, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 22, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Disposable Medical Gloves Industry http://www.reportlinker.com/p098378/Global-Disposable-Medical-Gloves-Industry.html This report analyzes the worldwide markets...

Delcath Systems Receives Refusal to File Letter From FDA

February 22, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 22, 2011 /- Delcath Systems, Inc. (Nasdaq: DCTH ) announced today that the Company has received a "refusal to file" letter from the U.S. Food & Drug Administration (FDA) for the New Drug Application (NDA) for its proprietary chemosaturation system used in the treatment...

Advertisement

Enox Biopharma, Inc. to Present at IN3 West Investment in Innovation Conference.

February 22, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

VANCOUVER, British Columbia, Feb. 22, 2011 /- Enox Biopharma, Inc. CEO, John C. Rewcastle, Ph.D., will present at the IN3 West Investment in Innovation Conference on Thursday, February 24 at 11:05 AM PST. The conference is being held at the Venetian Hotel in Las Vegas. Dr. Rewcastle will...

Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional

February 21, 2011 10:36 pm | by Bio-Medicine.Org | News | Comments

NEW BRUNSWICK, N.J. and LEIDEN, Netherlands, Feb. 22, 2011 /- Johnson & Johnson (NYSE: JNJ ) and Crucell N.V. (NYSE Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX) today announce that Johnson & Johnson has completed the tender offer for Crucell N.V. (Crucell) and has declared the...

Acuo Technologies Announces Another Significant Growth Year in Revenue and Implementations to Further the Company's Market Leading Position

February 21, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

BLOOMINGTON, Minn., Feb. 21, 2011 /- Acuo Technologies®, a market leading provider of comprehensive software solutions to the medical imaging industry for archiving, collaboration and migration services, announces another year of significant growth during Fiscal Year 2010. The...

Acuo Technologies Announces New Enterprise Capabilities with Latest Software Release

February 21, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

BLOOMINGTON, Minn., Feb. 21, 2011 /- Acuo Technologies®, a market leading provider of comprehensive software solutions to the medical imaging industry for archiving, collaboration and migration services, is pleased to announce the availability of the latest release of its market...

SuccessEHS Announces its Enterprise Ambulatory EHR Solution for Hospitals

February 21, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

BIRMINGHAM, Ala., Feb. 21, 2011 /- SuccessEHS, a nationally recognized, streamlined practice management and electronic health record (EHR) vendor, has coupled its premier ambulatory care software solution with a signature Success Architecture to meet the ambulatory care needs of...

A Presidential Pardon on Joint Pain

February 21, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

BRADENTON, Fla., Feb. 21, 2011 /- Past presidents such as Gerald Ford, Ronald Reagan, and George H.W. Bush are among the millions of Americans who have undergone some form of joint replacement/repair surgery. While we see presidents come and go, advancements in joint replacement...

Sheffield Bio-Science and Wockhardt Announce Worldwide Exclusive Partnership to Supply Recombinant Insulin to Cell Culture Market

February 21, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

BELOIT, Wis., Feb. 21, 2011 /- Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for...

New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period(2)

February 20, 2011 6:35 pm | by Bio-Medicine.Org | News | Comments

LAWRENCE, Mass. and PHOENIX, Feb. 20, 2011 /- NxStage® Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study which show an increase in overall quality of life benefits,...

Saint Louis U Scientists Partner on Malaria Research

February 18, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Feb. 18, 2011 /PRNewswire-USNewswire/ --  The Center for World Health & Medicine at Saint Louis University and China's Guangzhou Institutes of Biomedicine and Health (GIBH) are forming a global research partnership that initially will focus on new treatments for...

Grifols Starts Construction of a New Plasma Fractionation Plant in Barcelona (Parets Del Valles)

February 18, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

BARCELONA, Spain, Feb. 18, 2011 /- Grifols, the Spanish group which specializes in the hospital-pharmaceutical sector and is one of the world's leading producers of plasma products, will shortly start construction of a new plant representing an investment of 20 million euros that will...

Smith & Nephew's Exclusive OXINIUMâ„¢ Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japanese Market

February 18, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn., Feb. 18, 2011 /- OXINIUM™ Oxidized Zirconium, the patented advanced bearing material from Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedics Division, has been awarded a C1 premium reimbursement classification in Japan for use in hip replacement surgery. The...

NACDS, NCPA Provide Insights to Governors and State Medicaid Directors Confronting Medicaid Budgetary Challenges

February 18, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

ALEXANDRIA, Va., Feb. 18, 2011 /PRNewswire-USNewswire/ -- The National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) have sent a joint letter to every Governor and State Medicaid Director, explaining the importance of pharmacies in...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading